Riley M. Hewko
Host: Legal Voice
Clara will protect and expand access to reproductive care, particularly for low-income women, using a variety of innovative legal and advocacy mechanisms, at a critical time when there is a substantial risk that the Supreme Court could decimate the right to an abortion.
Today, the right of women to obtain a legal abortion is in more danger than it has been in at least a generation. There is strong reason to believe that the newly constituted Supreme Court will uphold virtually any restriction on abortion access that comes before it, including those that would close clinics forcing women to travel hundreds of miles to other states in order to access safe reproductive care. The Court can make abortion as good as illegal for millions of American women, particularly low-income women and young women, even without overruling Roe v. Wade.
Clara will address head-on some of the new legal and practical questions that are being raised as women increasingly must travel out of state to get an abortion. The project also expands the capacity of the American Civil Liberties Union’s Reproductive Freedom Project and its partners to challenge unwarranted restrictions on access to abortion care at a particularly critical juncture. The project will focus on advising women, health care professionals, and organization partners in states where women need to seek alternative means to access care in order to address the substantial legal questions arising from this reality. It will also center around identify and implementing strategies for lifting existing barriers to care, as well as challenging new restrictions.
All women—not just those of means—should be able to make the best decision for herself and her family about whether and when to have children without undue state or political interference.
Clara Spera /
Equal Justice Works Fellow
Host: Legal Voice
Host: New York Civil Liberties Union
Host: National Women's Law Center
Sponsor: Greenberg Traurig, LLP
Host: Sanctuary for Families
Sponsor: Baker McKenzie, Merck & Co., Inc.